EP 1481009 A2 20041201 - PEPTIDES FOR USE IN ANTITUMOR IMMUNOTHERAPY
Title (en)
PEPTIDES FOR USE IN ANTITUMOR IMMUNOTHERAPY
Title (de)
PEPTIDE ZUR VERWENDUNG IM ANTI-TUMOR IMMUNOTHERAPIE
Title (fr)
PEPTIDES UTILISABLES EN IMMUNOTHERAPIE ANTITUMORALE.
Publication
Application
Priority
- FR 0300698 W 20030304
- FR 0202703 A 20020304
Abstract (en)
[origin: WO03074565A2] The invention concerns the use of immunogenic peptides representing T epitopes presented by the MHC I, derived from Melan-A, MAGE-A6, gp 100, tyrosinase and NY-ESO-1 antigens for the diagnosis or treatment of melanomas in HLA-B35 subjects.
IPC 1-7
C07K 14/47; A61K 38/17; C12N 15/12; C12N 5/08; C12P 37/04; C07K 19/00; C12N 15/62
IPC 8 full level
C12N 15/09 (2006.01); A61K 39/00 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 14/82 (2006.01); C12N 5/08 (2006.01); C12N 5/10 (2006.01); C12N 15/12 (2006.01)
CPC (source: EP US)
A61P 35/00 (2017.12 - EP); C07K 14/82 (2013.01 - EP US)
Citation (search report)
See references of WO 03074565A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03074565 A2 20030912; WO 03074565 A3 20040708; AU 2003232280 A1 20030916; AU 2003232280 A8 20030916; CA 2477762 A1 20030912; EP 1481009 A2 20041201; FR 2836684 A1 20030905; FR 2836684 B1 20041217; JP 2005533487 A 20051110; US 2006122119 A1 20060608
DOCDB simple family (application)
FR 0300698 W 20030304; AU 2003232280 A 20030304; CA 2477762 A 20030304; EP 03743400 A 20030304; FR 0202703 A 20020304; JP 2003573030 A 20030304; US 50633405 A 20050525